LARS Antikörper (HRP)
Kurzübersicht für LARS Antikörper (HRP) (ABIN8005827)
Target
Alle LARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Anti-Leucyl tRNA synthetase /LARS Antibody HRP Conjugated
-
Spezifität
- No cross reactivity with other proteins.
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E. coli-derived human Leucyl tRNA synthetase/LARS recombinant protein (Q628-Q855).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Andere Bezeichnung
- LARS
-
Hintergrund
-
Background: Leucyl-tRNA synthetase, cytoplasmic is an enzyme that in humans is encoded by the LARS gene. This gene is mapped to 5q32. It encodes a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. The encoded enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA (Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. A mutation in this gene was found in affected individuals with infantile liver failure syndrome 1. Alternatively spliced transcript variants of this gene have been observed.
Gene Full Name: leucyl-tRNA synthetase 1
-
Gen-ID
- 51520
-
UniProt
- Q9P2J5
-
Pathways
- EGFR Signaling Pathway
Target
-